Integrating Patient-Centric Clinical Pharmacology and MID3 to Advance Biologic Development in Immune-Mediated Inflammatory Diseases.

Ait-Oudhia S, Zhang L, Pisal DS, Cicali B.

Open source

DOI
10.1002/cpt.70471
Published
2026-09-03
Container
Clin Pharmacol Ther
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cpt.70471,
  title = {Integrating Patient-Centric Clinical Pharmacology and MID3 to Advance Biologic Development in Immune-Mediated Inflammatory Diseases.},
  author = {Ait-Oudhia S and  Zhang L and  Pisal DS and  Cicali B.},
  year = {2026},
  journal = {Clin Pharmacol Ther},
  doi = {10.1002/cpt.70471},
  url = {https://doi.org/10.1002/cpt.70471}
}

RIS

TY  - JOUR
TI  - Integrating Patient-Centric Clinical Pharmacology and MID3 to Advance Biologic Development in Immune-Mediated Inflammatory Diseases.
AU  - Ait-Oudhia S
AU  -  Zhang L
AU  -  Pisal DS
AU  -  Cicali B.
PY  - 2026
JO  - Clin Pharmacol Ther
DO  - 10.1002/cpt.70471
UR  - https://doi.org/10.1002/cpt.70471
ER  - 

APA

S, A., L, Z., DS, P., & B., C. (2026). Integrating Patient-Centric Clinical Pharmacology and MID3 to Advance Biologic Development in Immune-Mediated Inflammatory Diseases.. Clin Pharmacol Ther. https://doi.org/10.1002/cpt.70471

Source records